Back to search

Article

Upregulation of EMID1 accelerates to a favorable prognosis and immune infiltration in lung adenocarcinoma.

2020-05-18

Abstract excerpt

<h4>Background: </h4> Lung cancer is a kind of refractory cancer. Lung adenocarcinoma (LUAD) is the main subtype of lung cancer. Although there are many ways to treat lung cancer, the survival rate of patients has not improved. Therefore, more new molecules need to be found for the diagnosis and treatment of LUAD. Methods The data from The Cancer Genome Atlas (TCGA) database were used to analyze the value of EMID1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be19190b-f4a7-553a-b985-3ab3f75e6be1
DOI
10.21203/rs.3.rs-28724/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Upregulation of EMID1 accelerates to a favorable prognosis and immune infiltration in lung adenocarcinoma.DOI 10.21203/rs.3.rs-28724/v1
Overexpression of P4HA1 Is Correlated with Poor Survival and Immune Infiltrates in Lung Adenocarcinoma.Semantic proximity
Four and a half LIM domain protein 1 as a Novel Prognostic Biomarker and Correlation with Immune Infiltration Levels in Lung AdenocarcinomaSemantic proximity
Construction of a novel prognostic model for evaluation of immune infiltration and immunotherapy in lung adenocarcinomaSemantic proximity
The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinomaSemantic proximity
MDFI is a novel biomarker for poor prognosis in LUADSemantic proximity
Identification of molecular markers associated with the progression and prognosis of lung adenocarcinoma:a bioinformatic studySemantic proximity
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinomaSemantic proximity
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitorsSemantic proximity
Distinct Expression Pattern and Prognostic Values of E2F Family Genes in Lung Adenocarcinoma and Squamous Cell CarcinomaSemantic proximity
Identification of MCM4 as an independent prognostic factor and correlate with immune infiltration in Lung Adenocarcinoma through bioinformatics analysisSemantic proximity
Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinomaSemantic proximity
GIMAP8 is a promising prognostic biomarker correlated with immune infiltration in lung adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.